Highest-materiality recent filing
Chimera declares Q3 2026 preferred dividends for four series
Series A: $0.50/share, payable Sept 30, 2026 to holders of record Sept 1, 2026.
Chimera Q2 GAAP net loss $4M; EAD $0.46/share supports $0.45 dividend
GAAP net loss of $4M ($0.05 diluted EPS); EAD (non-GAAP) of $39M ($0.46/share).
Chimera Investment holds annual meeting; re-elects three directors, approves say-on-pay, ratifies EY
75.65% of shares present or proxied; all three Class I directors elected with 43M+ votes for each.
Chimera declares Q2 2026 dividend of $0.45 per share, maintaining $1.80 annualized rate
Q2 cash dividend of $0.45 per common share, unchanged from Q1 2026 and in line with Board's stated 2026 guidance.
Chimera declares Q2 2026 preferred dividends: Series A $0.50, B $0.6095, C $0.5561, D $0.5967
Q2 2026 dividends: Series A $0.50, Series B $0.6095, Series C $0.5561, Series D $0.5967 per share.
Chimera Q1 2026: GAAP loss $65M, EAD $0.54 supports $0.45 dividend
GAAP net loss $65M (-$0.78 diluted EPS); EAD (non-GAAP) $46M ($0.54/diluted share).
Chimera files investor presentation for SFVegas Conference; no details provided
Company posted investor presentation on website in connection with participation in SFVegas Conference.
Chimera increases Q1 2026 common dividend to $0.45 from $0.37; expects to maintain $0.45 for 2026
Q1 2026 common dividend $0.45/share (up from $0.37 in Q4 2025); payable April 30, 2026; record March 31, 2026.
Chimera Q4 GAAP net income $7M; EAD $0.53/sh; dividend increased
GAAP net income Q4 $7M ($0.08 diluted EPS); full year $144M ($1.72 diluted EPS).
Chimera declares Q4 2025 dividend of $0.37 per share, payable Jan 30, 2026
Dividend of $0.37 per common share for fourth quarter 2025.
Chimera reports Q3 GAAP net loss $0.27/sh; EAD $0.37; closes HomeXpress buy
GAAP net loss of $21.997M ($0.27 diluted loss per share); EAD of $30.255M ($0.37/adjusted diluted share).
Chimera declares Q4 2025 preferred dividends; Series A $0.50, B $0.6274, C $0.5681, D $0.6083
Board declares Q4 2025 cash dividend of $0.50 per share on Series A 8.00% Cumulative Redeemable Preferred Stock.
Total consideration: $119.5M adjusted book value, $120M cash premium, and 2,077,151 shares of CIM common stock.
Chimera Investment declares Q3 2025 dividend of $0.37 per common share
Q3 2025 common stock dividend set at $0.37 per share.
Chimera issues $120M of 8.875% senior notes due 2030, net proceeds ~$115.8M
$120M aggregate principal (incl. $5M over-allotment) of 8.875% senior notes due Aug 15, 2030.
Chimera Investment prices $115M of 8.875% Senior Notes due 2030
$115M aggregate principal of 8.875% Senior Notes due 2030 priced; underwriters have 30-day option for additional $17.25M.
Chimera Q2 GAAP EPS $0.17, EAD $0.39; agrees to acquire HomeXpress Mortgage
GAAP net income $0.17/diluted share; earnings available for distribution (non-GAAP) $0.39/adjusted diluted share.
Chimera declares Q3 2025 preferred dividends on all four series
Q3 2025 Series A dividend: $0.50/share, payable Sept 30, record Sept 2.
Chimera acquires HomeXpress Mortgage Corp. for $120M cash plus stock
Acquires all Capital Stock of HX Holdco Corp. and Management Held Company Stock from Seer Capital and management sellers.
Chimera acquires HomeXpress Mortgage; $120M cash + 2.08M shares premium, Q4 close
Purchase price equals adjusted book value at closing plus $120M cash and 2,077,151 Chimera shares.
Chimera declares Q2 2025 dividend of $0.37 per common share
Second quarter cash dividend of $0.37 per common share.
All three director nominees elected: Phillip J. Kardis II (Class II), Brian P. Reilly and Cynthia B. Walsh (Class III).
Chimera Q1 GAAP EPS $1.77, EAD $0.41, BV $21.17, economic return 9.2%
GAAP net income $1.77 per diluted share; earnings available for distribution $0.41 per share (up 11% sequentially).
Chimera declares Q2 2025 preferred dividends on Series A, B, C, D
Series A: $0.50/share; Series B: $0.6469/share; Series C: $0.484375/share; Series D: $0.6349/share.
Independent Director Sandra Bell resigns from Chimera Board; no disagreement cited
Sandra Bell resigned as independent Board member effective April 9, 2025.
Chimera Investment Corp Chief Credit & Risk Officer Dan Thakkar to step down effective July 1, 2025
Dan Thakkar mutually agrees to step down as Chief Credit & Risk Officer, effective July 1, 2025; garden leave begins April 2, 2025.
Chimera sponsors two residential mortgage loan securitizations totaling $646M
Sponsored CIM 2025-R1 ($391.8M) and CIM 2025-NR1 ($254.4M) securitizations on March 25, 2025.
Chimera declares Q1 2025 dividend of $0.37 per common share
Dividend of $0.37 per common share for the first quarter of 2025.
Chimera posts investor presentation for RBC conference; no material financial details in 8-K
Made investor presentation available on its website for RBC Capital Markets Global Financial Institutions Conference.
Chimera reports Q4 2024 GAAP net loss of $2.07 per share; core EAD $0.37 per share
Q4 GAAP net loss of $2.07 per diluted common share; full year GAAP net income of $1.10 per share.
Chimera Q4 2024 GAAP net loss of $2.04 per share; full year net income $1.10 per share
Q4 2024 GAAP net loss of $2.04 per diluted common share; full year GAAP net income $1.10 per share.
Chimera declares Q1 2025 preferred stock dividends: Series A $0.50, B $0.6488, C $0.4844, D $0.6231
Dividends payable March 31, 2025 to holders of record March 3, 2025; ex-dividend date March 3, 2025.
Chimera sponsors $287.7M residential mortgage loan securitization CIM 2025-I1
Securitization of $287.7M residential mortgage investor loans with 7.9% weighted avg coupon.
Chimera Investment Corp declares Q4 2024 dividend of $0.37 per share
Dividend of $0.37 per common share declared for Q4 2024.
Chimera completes $30M acquisition of Palisades Group; Jack Macdowell named CIO
Acquisition of Palisades Group closed Dec 2, 2024 for $30M cash plus up to $20M earnout over 5 years.
Chimera Investment Corporation declares fourth quarter 2024 dividends on preferred stock
Declares $0.50 per share dividend on 8% Series A Cumulative Redeemable Preferred Stock.
Cynthia B. Walsh elected to Chimera's Board as Class III Director, effective December 1, 2024.
Chimera Q3 GAAP EPS $1.39, book value $22.35, economic return 6.82%
GAAP net income of $1.39 per diluted common share, up from $0.41 in Q2; earnings available for distribution of $0.36 per share.
Chimera to acquire Palisades Group for $30M upfront plus up to $20M earnout
Upfront cash consideration of $30M; earnout up to $20M over 5 yrs based on revenue targets.
Chimera Investment Corp increases Q3 2024 common dividend to $0.37 per share
Q3 2024 cash dividend of $0.37 per common share, an increase from the prior quarter.
Chimera issues $74.75M of 9.250% Senior Notes due 2029
Notes bear interest at 9.250% per year, payable quarterly, mature Aug 15, 2029.
Chimera prices $65M of 9.250% Senior Notes due 2029 in underwritten offering
Priced $65M aggregate principal amount of 9.250% Senior Notes due 2029.
Board declares Q3 2024 cash dividend of $0.50 per share on 8% Series A Cumulative Redeemable Preferred Stock.
Chimera Q2 GAAP net income $0.41/diluted share, EAD $0.37; BV $21.27, economic return 1.4%
Q2 GAAP net income $33.9M ($0.41 diluted EPS) vs $111.0M ($1.36) in Q1; drop due to lower unrealized gains.
Chimera sponsors $468.1M securitization of reperforming residential mortgage loans
CIM 2024-R1 securitization totals $468.1M; $351.8M senior notes sold to institutional investors at 75.15% advance rate.
Chimera Investment increases Q2 2024 common dividend to $0.35 per share
Q2 2024 cash dividend of $0.35 per common share, up from $0.33 in Q1 2024 on a reverse-split adjusted basis.
Chimera annual meeting elects three directors; say-on-pay, auditor ratified
Susan Mills elected Class I director; Sandra Bell and Debra W. Still elected Class II directors, terms through 2026/2027.
Chimera Investment Corp issues $65M of 9.000% Senior Notes due 2029
Issued $65 million aggregate principal amount of 9.000% Senior Notes due May 15, 2029.
Chimera Investment Corporation effects 1-for-3 reverse stock split effective May 21, 2024
1-for-3 reverse stock split of common stock effective after close on May 21, 2024.
Chimera Investment prices $65M of 9.000% Senior Notes due 2029
Offering of $65M aggregate principal of 9.000% Senior Notes due 2029; underwriters have 30-day option for additional $9.75M.
On April 9, 2025, Sandra Bell, an independent member of the board of directors (the “Board”) of Chimera Investment Corporation (the “Company”), notified the Company that she intends to resign from the Board, effective immediately.
On April 2, 2025, Chimera Investment Corporation (the “Company”) and Dan Thakkar mutually agreed that Mr. Thakkar will step down from his position as the Company’s Chief Credit & Risk Officer, effective July 1, 2025
On November 5, 2024, the Board of Directors (the “Board”) of Chimera Investment Corporation (the “Company”) elected Cynthia B. Walsh to the Company’s Board as a Class III Director, effective December 1, 2024.
On March 18, 2024, Phillip J. Kardis II, the Chief Executive Officer of Chimera Investment Corporation (the “ Company ”), was appointed the President of the Company to assume the position previously held by Mr. Choudhary Yarlagadda, who retired from the Company on March 15, 2024.
On February 5, 2024, Subramaniam Viswanathan, the Chief Financial Officer of Chimera Investment Corporation (the “ Company ”), was designated as the principal accounting officer.
Choudhary Yarlagadda mutually agreed that Mr. Yarlagadda will retire from employment with the Company and resign from the Board of Directors of the Company (the “ Board ”), effective (i) March 31, 2024
Susan Mills has been appointed to the Company’s Board of Directors (the “Board”) as a Class I Director, effective November 13, 2023.
On December 31, 2022, Mr. Marria entered into a separation agreement and general release (the “Separation Agreement”) with the Company, which provides for pay in lieu of notice and severance payments and benefits pursuant to the terms of his employment agreement with the Company, effective January 1, 2019 (the “Employment Agreement”), as previously filed with the Securities and Exchange Commission, for a termination without cause, subject to his not revoking the Separation Agreement within a seven day revocation period and his complying with post-termination restrictive covenants.
On December 10, 2022, it was determined that Mr. Marria will separate from employment with the Company as the Company’s Chief Executive Officer ("CEO") and Chief Investment Officer ("CIO"), effective December 10, 2022.
Mr. Kardis concurrently resigned from his roles as CLO and Secretary
On December 10, 2022, it was determined that Mr. Marria will separate from employment with the Company as the Company’s Chief Executive Officer ("CEO") and Chief Investment Officer ("CIO"), effective December 10, 2022.
Additionally, Mr. Marria resigned from the Company’s Board of Directors (the "Board"), effective December 10, 2022.
Max materiality 0.85 · Median 0.53 · Most common event dividend